Close Menu

There is a wager between Lewis Wolpert and Rupert Sheldrake on the predictive value of the genome, to be decided on May 1, 2029. The winner gets a case of port. Wolpert, an embryologist at University College, London, says that by that date, researchers will be able to predict all the details and any abnormalities of an organism from the genome of the fertilized egg. Sheldrake, a parapsychologist, says that will not be possible.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.